Search

You searched for "interventions"

1955 results found

Triamcinolone (TA) deposits following subcutaneous injection to treat chalazion

2 August 2022 | | EYE - Oculoplastic, EYE - General
Chalazia are chronic lipogranulomatous inflammations of the eyelid secondary to a blocked meibomian gland. Whilst most resolve spontaneously, certain chalazia warrant treatment. Options include incision and curettage (I&C), lesion excision, intralesional steroid injections, and botox injections [1]. I&C is usually...

Patient safety – is this achieved in optometry with CET?

1 August 2018 | | EYE - General
Collecting points and ticking boxes – as we come to the end of another three year cycle of continuing education and training (CET), the rush to ensure that everything has been completed on the myGOC (General Optical Council) dashboard feels...

Do patient demographics influence AMD clinic attendance during COVID-19 lockdown?

3 June 2021 | | EYE - Vitreo-Retinal
The authors assess the impact of the COVID-19 pandemic on adherence to scheduled clinic appointments among age-related macular degeneration patients in a clinic in North Wales. The COVID-19 pandemic has significantly affected the population, affecting economic and social wellbeing, whilst...

NHS Practitioner Health releases National Guide for Health and Care Professionals Affected by Suicide

30 September 2025 | wellbeing, NHS Practitioner Health, burnout, mental health, standards
To mark the second year of the UK’s National Suicide Memorial Day for Health and Care Workers, NHS Practitioner Health will launch a suicide prevention and postvention navigation guide for health and care professionals. The National Suicide Memorial Day for...

“Beware of the pigment”

4 August 2021 | | EYE - Glaucoma, EYE - General
Using some captivating artwork, Iheukwumere Duru describes key features of pigment dispersion syndrome. Pigmentary dispersion syndrome (PDS) leads to pigmentary glaucoma (PG) in approximately 35-50% of patients with the condition [1]. PG is the leading cause of non-traumatic blindness in...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Headset perimetry

3 April 2023 | | EYE - General
Visual field analysers are traditionally large table mounted devices, designed specifically for field capture and analysis. Over the last year or so a number of companies have started to disrupt this space with the introduction of headset-based field analysers, mostly...

Choroidal melanoma – breaking bad news

1 June 2019 | | EYE - Pathology, EYE - Oncology
Case report A 55-year-old Caucasian female presented to her general practitioner with a three-month history of headaches and worsening blurred vision in the left eye. On further close questioning, she reported no eye pain, intermittent floaters and flashes of light...

Archery enthusiast’s sight is back on target following ‘life-changing’ eye surgery for cataracts

16 December 2022
Retired bus driver and keen archer Roger Kent is feeling grateful for his improved quality of life after undergoing successful cataract surgery at Freedom Vision in Bolton.

Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds

14 February 2025 | research, genetics, gene therapy, pathology, education, Adeno-Associated Virus, inflammation
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...

New research shows the unhealthy state of access to medicine and medical devices for blind patients

30 April 2025 | RNIB, The Safety Gap, risk assessment, diabetes, patient experience, public awareness
Blind and partially sighted people could become ill from medicines and medical devices, because they are not being listened to when it comes to designing, prescribing and administering treatments. The Safety Gap’ report commissioned by the Patient Safety Commissioner, Prof...

Protecting and recovering from email hacking

1 February 2016 |
Over the last 12 months I have received emails from more than 20 friends and acquaintances (mostly doctors) who didn’t send those emails. More often than not I find the emails in my ‘Spam’ folder as Gmail knows they are...